Balakrishna, Vinod Anera, Anitha Police, Rakesh Hiremath, Anusha Raj, Suresh P Sulochana, Devaraj V Chandrasekhar, Zainuddin Mohd, Ravi Kanth Bhamidipati, and Ramesh Mullangi. “Preclinical Assessment of Ulixertinib, a Novel ERK1/2 Inhibitor”. ADMET and DMPK 5, no. 4 (December 23, 2017): 212–223. Accessed February 16, 2025. https://pub.iapchem.org/ojs/index.php/admet/article/view/437.